Brenner Alex W, Patel Akash J
Department of Neurosurgery, Baylor College of Medicine, Houston, TX, United States.
Front Oncol. 2022 May 24;12:857622. doi: 10.3389/fonc.2022.857622. eCollection 2022.
Brain metastases are the most common intracranial tumors and are increasing in incidence as overall cancer survival improves. Diagnosis of brain metastases involves both clinical examination and magnetic resonance imaging. Treatment may involve a combination of surgery, radiotherapy, and systemic medical therapy depending on the patient's neurologic status, performance status, and overall oncologic burden. Advances in these domains have substantially impacted the management of brain metastases and improved performance status and survival for some patients. Indications for surgery have expanded with improved patient selection, imaging, and intraoperative monitoring. Robust evidence supports the use of whole brain radiotherapy and stereotactic radiosurgery, for both standalone and adjuvant indications, in almost all patients. Lastly, while systemic medical therapy has historically provided little benefit, modern immunotherapeutic agents have demonstrated promise. Current investigation seeks to determine the utility of neoadjuvant radiotherapy and laser interstitial thermal therapy, which have shown benefit in limited studies to date. This article provides a review of the epidemiology, pathology, diagnosis, and treatment of brain metastases and the corresponding supporting evidence.
脑转移瘤是最常见的颅内肿瘤,随着癌症总体生存率的提高,其发病率也在上升。脑转移瘤的诊断涉及临床检查和磁共振成像。治疗可能包括手术、放疗和全身药物治疗的联合应用,具体取决于患者的神经状态、功能状态和总体肿瘤负荷。这些领域的进展对脑转移瘤的管理产生了重大影响,并改善了一些患者的功能状态和生存率。随着患者选择、影像学检查和术中监测的改善,手术指征有所扩大。强有力的证据支持在几乎所有患者中,单独或辅助使用全脑放疗和立体定向放射外科。最后,虽然全身药物治疗在历史上获益甚微,但现代免疫治疗药物已显示出前景。目前的研究旨在确定新辅助放疗和激光间质热疗的效用,迄今为止,这些治疗在有限的研究中已显示出益处。本文综述了脑转移瘤的流行病学、病理学、诊断、治疗及相应的支持证据。